| *René Thierbach, Tim J. Schulz, Frank Isken, Anja Voigt, Brun Mietzner, Gunnar Drewes, Jürgen-Christoph von Kleist-Retzow, Rudolf J. Wiesner, Mark A. Magnuson, Hélène Puccio, Andreas F.H. Pfeiffer, Pablo Steinberg und Michael Ristow: „Targeted Disruption of Hepatic Frataxin Expression Causes Impaired Mitochondrial Function, Decreased Life Span and Tumor Growth in Mice", Human Molecular Genetics, Vol. 14, Nr. 24, 15.12.2005, Seiten 3857–3864. | | *René Thierbach, Tim J. Schulz, Frank Isken, Anja Voigt, Brun Mietzner, Gunnar Drewes, Jürgen-Christoph von Kleist-Retzow, Rudolf J. Wiesner, Mark A. Magnuson, Hélène Puccio, Andreas F.H. Pfeiffer, Pablo Steinberg und Michael Ristow: „Targeted Disruption of Hepatic Frataxin Expression Causes Impaired Mitochondrial Function, Decreased Life Span and Tumor Growth in Mice", Human Molecular Genetics, Vol. 14, Nr. 24, 15.12.2005, Seiten 3857–3864. |
| *Coy, S. Langbein et al.: „Frataxin Inhibts Cancer Growth: Otto Warburg Revisited", British Journal of Cancer, Vol. 94: Seiten 578–85. | | *Coy, S. Langbein et al.: „Frataxin Inhibts Cancer Growth: Otto Warburg Revisited", British Journal of Cancer, Vol. 94: Seiten 578–85. |